Your browser doesn't support javascript.
loading
Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study.
Zhao, Guangyin; Zhang, Hongyu; Xu, Fengkai; Lu, Chunlai; Zhu, Qiaoliang; Grossi, Francesco; Divisi, Duilio; Ma, Teng; Gu, Jie; Ge, Di.
Afiliação
  • Zhao G; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang H; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xu F; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lu C; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhu Q; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Grossi F; Medical Oncology Unit, Department of Medicine and Surgery, University of Insubria, ASST dei Sette Laghi, Varese, Italy.
  • Divisi D; Department of Life, Health and Environmental Sciences, University of L'Aquila, Thoracic Surgery Unit, "Giuseppe Mazzini" Hospital of Teramo, Teramo, Italy.
  • Ma T; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Gu J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ge D; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Transl Lung Cancer Res ; 12(1): 141-149, 2023 Jan 31.
Article em En | MEDLINE | ID: mdl-36762056

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article